Free Trial
NYSE:CLB

Core Laboratories (CLB) Stock Price, News & Analysis

$24.20
-0.15 (-0.62%)
(As of 07/26/2024 ET)
Today's Range
$23.64
$24.51
50-Day Range
$17.87
$24.36
52-Week Range
$13.82
$27.94
Volume
519,835 shs
Average Volume
455,913 shs
Market Capitalization
$1.14 billion
P/E Ratio
27.51
Dividend Yield
0.17%
Price Target
$17.50

Core Laboratories MarketRank™ Stock Analysis

Analyst Rating
Reduce
1.50 Rating Score
Upside/​Downside
23.5% Downside
$18.50 Price Target
Short Interest
Bearish
15.76% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.26mentions of Core Laboratories in the last 14 days
Based on 20 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
47.89%
From $0.71 to $1.05 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.79 out of 5 stars

Oils/Energy Sector

231st out of 248 stocks

Oil & Gas Field Services, Not Elsewhere Classified Industry

16th out of 18 stocks

CLB stock logo

About Core Laboratories Stock (NYSE:CLB)

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

CLB Stock Price History

CLB Stock News Headlines

Brace Yourself: Experts calling for Bitcoin to hit $100k
For the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.
CORE LAB REPORTS SECOND QUARTER 2024 RESULTS
Here's what Wall Street expects from Core Laboratories's earnings report
Brace Yourself: Experts calling for Bitcoin to hit $100k
For the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.
Core Laboratories (CLB) Set to Announce Earnings on Wednesday
Core Laboratories Inc. (CLB)
See More Headlines
Receive CLB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 5/28 Dividend
5/03/2024
Dividend Payable
5/28/2024
Last Earnings
7/24/2024
Today
7/26/2024
Ex-Dividend for 8/26 Dividend
8/05/2024
Dividend Payable
8/26/2024
Next Earnings (Estimated)
11/06/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Oil & gas field services, not elsewhere classified
Sub-Industry
N/A
Fax
N/A
Employees
3,600
Year Founded
1936

Price Target and Rating

Average Stock Price Target
$17.50
High Stock Price Target
$20.00
Low Stock Price Target
$15.00
Potential Upside/Downside
-27.0%
Consensus Rating
Reduce
Rating Score (0-4)
1.50
Research Coverage
4 Analysts

Profitability

Net Income
$36.67 million
Pretax Margin
8.47%

Debt

Sales & Book Value

Annual Sales
$509.79 million
Cash Flow
$1.16 per share
Book Value
$4.92 per share

Miscellaneous

Free Float
46,544,000
Market Cap
$1.12 billion
Optionable
Optionable
Beta
2.41

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Key Executives

  • Mr. Lawrence V. Bruno (Age 63)
    Chairman of the Board, CEO, President & COO
    Comp: $1.47M
  • Mr. Christopher Scott Hill (Age 54)
    Senior VP & CFO
    Comp: $668.8k
  • Ms. Gwendolyn Y. Gresham M.B.A. (Age 56)
    Senior Vice President of Corporate Development & Investor Relations
    Comp: $574.19k
  • Mr. Mark Damian Tattoli (Age 52)
    Senior VP, Secretary & General Counsel
    Comp: $565.11k
  • Mr. Sow Hang Teo (Age 54)
    VP, Treasurer & Chief Accounting Officer
  • Mr. Jacobus Schouten (Age 69)
    Managing Director
    Comp: $26.35k
  • J. Donald Dumas Jr.
    Senior VP of Production Enhancement & Business Development

CLB Stock Analysis - Frequently Asked Questions

How have CLB shares performed this year?

Core Laboratories' stock was trading at $17.66 at the beginning of 2024. Since then, CLB shares have increased by 36.9% and is now trading at $24.17.
View the best growth stocks for 2024 here
.

How were Core Laboratories' earnings last quarter?

Core Laboratories Inc. (NYSE:CLB) issued its earnings results on Wednesday, July, 24th. The oil and gas company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.21 by $0.01. Core Laboratories's quarterly revenue was up 2.1% compared to the same quarter last year.

What is David M. Demshur's approval rating as Core Laboratories' CEO?

60 employees have rated Core Laboratories Chief Executive Officer David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among the company's employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Core Laboratories' major shareholders?

Top institutional investors of Core Laboratories include Boston Trust Walden Corp (1.56%), Bank of New York Mellon Corp (1.10%), Confluence Investment Management LLC (0.30%) and Partnership Wealth Management LLC (0.17%).
View institutional ownership trends
.

How do I buy shares of Core Laboratories?

Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Core Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX) and Intel (INTC).

This page (NYSE:CLB) was last updated on 7/26/2024 by MarketBeat.com Staff

From Our Partners